Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.18 - $4.29 $26,253 - $51,664
-12,043 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.25 - $7.12 $27,096 - $85,746
12,043 New
12,043 $37,000
Q2 2020

Aug 14, 2020

SELL
$2.37 - $7.14 $31,087 - $93,655
-13,117 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$2.46 - $5.84 $9,015 - $21,403
-3,665 Reduced 21.84%
13,117 $35,000
Q4 2019

Feb 14, 2020

BUY
$1.8 - $13.43 $30,207 - $225,382
16,782 New
16,782 $46,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0

About Cyclerion Therapeutics, Inc.


  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $139M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.